Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630 (Q36027650)

11 August 2017

Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630 (English)

1 reference

11 August 2017

Plowman PN

1

1 reference

11 August 2017

Nicholson RI

series ordinal

2

1 reference

11 August 2017

Walker KJ

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

54

1 reference

11 August 2017

6

1 reference

11 August 2017

903-909

1 reference

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001583

Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001583

Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001583

Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001583

The measurement of human gonadotrophins by radioimmunoassay

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001583

Testosterone Secretion by Cultured Arrhenoblastoma Cells: Suppression by a Luteinizing Hormone-Releasing Hormone Agonist

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001583

A simple, direct radioimmunoassay for plasma cortisol, featuring a 125I radioligand and a solid-phase separation technique

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001583

A Simple Robust Assay for Testosterone in Male Plasma Using an125I-Radioligand and a Solid-Phase Separation Technique

11 July 2018

1 reference

12 December 2020

Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?

1 reference

12 December 2020

Gonadotropin-releasing hormone binding sites in human breast carcinoma

1 reference

12 December 2020

Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma

1 reference

12 December 2020

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

1 reference

12 December 2020

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1986.260

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

2948537

1 reference